Descriptions

The autoinhibited protein was predicted that may have potential autoinhibitory elements via cis-regPred.

Autoinhibitory domains (AIDs)

Target domain

Relief mechanism

Assay

cis-regPred

Accessory elements

No accessory elements

Autoinhibited structure

Activated structure

2 structures for Q8TCJ2

Entry ID Method Resolution Chain Position Source
6S7T EM 350 A A 1-826 PDB
AF-Q8TCJ2-F1 Predicted AlphaFoldDB

403 variants for Q8TCJ2

Variant ID(s) Position Change Description Diseaes Association Provenance
CA351830904
rs1250170448
RCV001346781
4 P>L STT3B-congenital disorder of glycosylation [ClinVar] Yes ClinGen
ClinVar
dbSNP
gnomAD
RCV000871469
CA2294879
rs527396203
46 G>S STT3B-congenital disorder of glycosylation [ClinVar] Yes ClinGen
ClinVar
1000Genomes
ExAC
TOPMed
dbSNP
gnomAD
CA2294977
RCV000626086
rs780102016
207 I>V STT3B-congenital disorder of glycosylation [ClinVar] Yes ClinGen
ClinVar
ExAC
TOPMed
dbSNP
gnomAD
CA72539702
RCV000807197
rs1008042824
253 C>S STT3B-congenital disorder of glycosylation [ClinVar] Yes ClinGen
ClinVar
TOPMed
dbSNP
gnomAD
CA2295064
RCV000709840
RCV002534482
rs141238380
299 I>V STT3B-congenital disorder of glycosylation Inborn genetic diseases [ClinVar] Yes ClinGen
ClinVar
1000Genomes
ESP
ExAC
TOPMed
dbSNP
gnomAD
RCV001053313
rs559861697
CA2295194
448 I>V STT3B-congenital disorder of glycosylation [ClinVar] Yes ClinGen
ClinVar
1000Genomes
ExAC
TOPMed
dbSNP
gnomAD
rs949533229
CA72518587
RCV001247933
691 R>Q STT3B-congenital disorder of glycosylation [ClinVar] Yes ClinGen
ClinVar
TOPMed
dbSNP
gnomAD
RCV000811239
rs139208333
CA2295399
789 N>S STT3B-congenital disorder of glycosylation [ClinVar] Yes ClinGen
ClinVar
ESP
ExAC
TOPMed
dbSNP
gnomAD
CA2294843
rs764441079
3 E>Q No ClinGen
ExAC
gnomAD
COSM1186222
rs1460014436
CA351830909
5 S>L lung [Cosmic] No ClinGen
cosmic curated
gnomAD
rs765561784
CA2294846
6 A>T No ClinGen
ExAC
gnomAD
CA2294849
rs781154176
7 P>L No ClinGen
ExAC
TOPMed
gnomAD
rs754865944
CA2294848
7 P>S No ClinGen
ExAC
TOPMed
gnomAD
rs756137814
CA351830925
CA2294851
8 E>D No ClinGen
ExAC
gnomAD
CA2294850
rs747909324
8 E>G No ClinGen
ExAC
gnomAD
CA72669574
rs917752594
9 S>G No ClinGen
TOPMed
CA351830926
rs917752594
9 S>R No ClinGen
TOPMed
CA351830938
rs1575399079
10 K>M No ClinGen
Ensembl
CA2294852
rs777560756
11 H>P No ClinGen
ExAC
TOPMed
gnomAD
CA72669618
rs777560756
11 H>R No ClinGen
ExAC
TOPMed
gnomAD
CA72669588
rs966597028
11 H>Y No ClinGen
TOPMed
gnomAD
rs770317151
CA2294854
13 S>A No ClinGen
ExAC
gnomAD
rs770317151
CA351830955
13 S>P No ClinGen
ExAC
gnomAD
rs745544339
CA2294856
15 L>R No ClinGen
ExAC
TOPMed
gnomAD
rs775835448
CA2294858
16 N>S No ClinGen
ExAC
TOPMed
gnomAD
rs573987136
CA351830986
18 S>C No ClinGen
1000Genomes
TOPMed
gnomAD
rs573987136
CA72669662
18 S>F No ClinGen
1000Genomes
TOPMed
gnomAD
CA351830983
rs1303371160
18 S>T No ClinGen
TOPMed
CA2294860
rs764719664
21 S>G No ClinGen
ExAC
gnomAD
rs541845381
CA2294861
21 S>I No ClinGen
1000Genomes
ExAC
gnomAD
CA351831005
rs541845381
21 S>N No ClinGen
1000Genomes
ExAC
gnomAD
rs761989050
CA2294862
22 G>S No ClinGen
ExAC
TOPMed
gnomAD
rs750479085
CA2294864
23 L>F No ClinGen
ExAC
gnomAD
CA351831024
rs1431257226
24 M>I No ClinGen
TOPMed
CA2294865
rs758722499
24 M>K No ClinGen
ExAC
gnomAD
CA351831027
rs1426753258
25 A>T No ClinGen
gnomAD
CA351831045
rs1403658593
28 N>D No ClinGen
gnomAD
CA2294868
rs755861870
28 N>T No ClinGen
ExAC
gnomAD
CA351831061
rs1201721189
30 R>P No ClinGen
TOPMed
CA351831070
rs1415821617
31 H>Q No ClinGen
TOPMed
rs559864915
CA2294870
31 H>Y No ClinGen
1000Genomes
ExAC
gnomAD
rs1268634826
CA351831081
33 H>L No ClinGen
TOPMed
rs757170322
CA2294871
33 H>Y No ClinGen
ExAC
gnomAD
CA351831085
rs916630766
34 H>D No ClinGen
TOPMed
rs916630766
CA72669778
34 H>N No ClinGen
TOPMed
CA351831087
rs1484171472
34 H>R No ClinGen
TOPMed
TCGA novel 36 P>A Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA2294873
CA2294874
rs745319362
37 G>R No ClinGen
ExAC
TOPMed
gnomAD
rs1483374018
CA351831119
39 Q>H No ClinGen
TOPMed
gnomAD
rs777239381
CA2294878
44 A>E No ClinGen
ExAC
TOPMed
gnomAD
rs1350699081
CA351831156
45 A>T No ClinGen
TOPMed
rs527396203
CA2294880
46 G>C No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
CA351831175
rs1258715301
48 A>E No ClinGen
TOPMed
gnomAD
rs1258715301
CA351831177
48 A>V No ClinGen
TOPMed
gnomAD
CA351831194
rs1575399242
51 P>R No ClinGen
Ensembl
CA72669807
rs1037500037
53 P>L No ClinGen
TOPMed
gnomAD
CA72669814
rs900382616
54 A>V No ClinGen
TOPMed
CA2294882
rs763113809
55 P>A No ClinGen
ExAC
TOPMed
gnomAD
rs763113809
CA351831215
55 P>S No ClinGen
ExAC
TOPMed
gnomAD
rs1181427766
CA351831220
56 A>P No ClinGen
TOPMed
rs1181427766
CA351831219
56 A>T No ClinGen
TOPMed
TCGA novel 62 L>C Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs545539200
CA72669839
65 P>L No ClinGen
1000Genomes
rs751804567
CA2294884
66 A>G No ClinGen
ExAC
TOPMed
gnomAD
CA351831380
rs1484819748
70 S>W No ClinGen
gnomAD
CA2294886
rs763819212
72 L>V No ClinGen
ExAC
gnomAD
CA351831417
rs1269744838
74 F>L No ClinGen
gnomAD
rs1341681413
CA351831445
76 I>V No ClinGen
TOPMed
CA351831459
rs1289544358
77 L>V No ClinGen
gnomAD
rs1210264930
CA351831481
78 F>L No ClinGen
gnomAD
CA351831490
rs1444994022
79 L>Q No ClinGen
gnomAD
rs1269007117
CA351831487
79 L>V No ClinGen
TOPMed
gnomAD
rs749991781
CA2294890
82 L>V No ClinGen
ExAC
gnomAD
CA351831538
rs1459140990
83 A>G No ClinGen
TOPMed
CA351831548
rs1575399333
84 G>D No ClinGen
Ensembl
rs779722092
CA2294892
84 G>S No ClinGen
ExAC
gnomAD
rs1424396154
CA351831580
86 S>T No ClinGen
gnomAD
rs1294543005
CA351831598
87 S>L No ClinGen
gnomAD
CA351831615
rs1393138215
89 L>F No ClinGen
gnomAD
CA351831618
rs1158141423
89 L>H No ClinGen
TOPMed
rs1365972051
CA351831645
92 V>I No ClinGen
gnomAD
CA351831686
rs1312802453
95 F>C No ClinGen
gnomAD
CA2294898
rs773854046
98 I>V No ClinGen
ExAC
gnomAD
CA72521094
rs1028096653
108 Y>C No ClinGen
TOPMed
CA2294921
rs772238681
111 T>A No ClinGen
ExAC
TOPMed
gnomAD
rs952640283
CA72521099
112 H>Y No ClinGen
TOPMed
rs775070958
CA351813846
113 H>L No ClinGen
ExAC
TOPMed
gnomAD
CA2294922
rs775070958
113 H>R No ClinGen
ExAC
TOPMed
gnomAD
rs761552097
CA351813881
116 S>C No ClinGen
ExAC
TOPMed
gnomAD
rs761552097
CA2294923
116 S>F No ClinGen
ExAC
TOPMed
gnomAD
rs1288824366
CA351813892
117 H>R No ClinGen
gnomAD
rs772938941
CA2294925
119 F>V No ClinGen
ExAC
gnomAD
CA351813931
rs1428442420
120 Y>C No ClinGen
TOPMed
rs1171193780
CA351813941
121 E>K No ClinGen
TOPMed
CA2294926
rs762906069
123 L>F No ClinGen
ExAC
TOPMed
gnomAD
rs540782850
CA2294928
124 N>D No ClinGen
1000Genomes
ExAC
gnomAD
CA2294927
rs540782850
124 N>H No ClinGen
1000Genomes
ExAC
gnomAD
TCGA novel 128 E>* Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs767118074
CA2294930
129 R>K No ClinGen
ExAC
CA2294931
rs752375633
129 R>S No ClinGen
ExAC
CA351814168
rs1479982008
130 A>S No ClinGen
gnomAD
TCGA novel 130 A>T Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs200457651
CA2294934
131 W>C No ClinGen
ExAC
gnomAD
rs1169100350
CA351814456
142 V>F No ClinGen
gnomAD
TCGA novel 144 P>L Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA2294949
rs759021325
147 M>V No ClinGen
ExAC
gnomAD
rs767080550
CA2294950
149 T>N No ClinGen
ExAC
gnomAD
rs755833826
CA2294953
150 A>S No ClinGen
ExAC
TOPMed
gnomAD
rs755833826
CA2294952
150 A>T No ClinGen
ExAC
TOPMed
gnomAD
CA351814553
rs368969973
152 L>I No ClinGen
ESP
ExAC
gnomAD
CA2294954
rs368969973
152 L>V No ClinGen
ESP
ExAC
gnomAD
CA351814563
rs1363775875
153 I>V No ClinGen
TOPMed
gnomAD
rs757689083
CA2294955
154 H>R No ClinGen
ExAC
gnomAD
CA351814628
rs1298956272
157 L>F No ClinGen
gnomAD
CA2294958
rs140306636
162 I>V No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs1322713584
CA351814706
163 T>I No ClinGen
gnomAD
CA351814712
rs1223992368
164 V>I No ClinGen
TOPMed
gnomAD
TCGA novel 164 V>S Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA72523692
rs71323052
167 R>K No ClinGen
Ensembl
CA72523701
rs71323053
168 D>N No ClinGen
Ensembl
rs747021223
CA2294960
169 V>I Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
TOPMed
gnomAD
rs1438170970
CA351814840
174 A>V No ClinGen
TOPMed
CA2294965
COSM185385
rs773972695
179 G>S Variant assessed as Somatic; 0.0 impact. large_intestine [NCI-TCGA, Cosmic] No ClinGen
cosmic curated
ExAC
NCI-TCGA
gnomAD
rs1406907362
CA351814922
182 S>A No ClinGen
gnomAD
rs1280369912
CA351814937
183 I>M No ClinGen
TOPMed
rs759549093
CA2294966
183 I>V No ClinGen
ExAC
gnomAD
rs1387511452
CA351814946
184 S>F No ClinGen
gnomAD
CA2294967
rs771842134
185 T>A No ClinGen
ExAC
gnomAD
rs1322054500
CA351814984
188 L>H No ClinGen
gnomAD
CA2294968
rs775083191
189 T>A No ClinGen
ExAC
gnomAD
rs71323054
CA72523841
191 E>K No ClinGen
Ensembl
CA2294970
rs376965375
192 L>V No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA351815042
rs1380301371
194 N>D No ClinGen
gnomAD
rs753508197
CA2294971
197 A>G No ClinGen
ExAC
gnomAD
rs1230427294
CA351815067
197 A>T Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
NCI-TCGA
gnomAD
rs1209603060
CA351815071
198 G>R No ClinGen
gnomAD
CA351815100
rs1238052753
202 A>V No ClinGen
gnomAD
rs758947705
CA2294975
203 C>S No ClinGen
ExAC
gnomAD
CA2294976
rs142677107
205 I>V No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs755043994
CA351815133
207 I>M No ClinGen
ExAC
gnomAD
CA351815141
rs1404478707
209 P>A No ClinGen
TOPMed
CA351815200
rs1457386357
217 A>S No ClinGen
gnomAD
CA351815287
rs1413445396
225 I>V No ClinGen
gnomAD
CA351815320
rs1334049146
228 F>S No ClinGen
gnomAD
rs555260194
CA2295003
239 K>I No ClinGen
1000Genomes
ExAC
gnomAD
rs1264810676
CA351816588
241 V>A No ClinGen
gnomAD
CA2295004
rs777848759
241 V>I No ClinGen
ExAC
gnomAD
rs1199148520
CA351816601
242 K>I No ClinGen
gnomAD
rs745745863
CA2295005
243 T>I No ClinGen
ExAC
TOPMed
gnomAD
rs199996092
CA72539683
247 F>L No ClinGen
Ensembl
rs948082027
CA72539691
250 M>I No ClinGen
TOPMed
CA2295008
rs746961657
250 M>V No ClinGen
ExAC
TOPMed
gnomAD
rs567611130
CA2295009
257 F>L No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
CA351816800
rs1170942509
257 F>V No ClinGen
TOPMed
gnomAD
TCGA novel 263 W>L Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1465881449
CA351817158
265 G>V Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
NCI-TCGA
gnomAD
rs964004762
CA72543027
268 F>Y No ClinGen
TOPMed
CA2295037
rs775832467
269 I>M No ClinGen
ExAC
gnomAD
rs764101279
CA2295039
271 N>S No ClinGen
ExAC
TOPMed
gnomAD
rs1232767889
CA351817195
271 N>Y No ClinGen
TOPMed
TCGA novel 272 L>F Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1030631008
CA72543104
279 V>G No ClinGen
TOPMed
CA351817252
rs1399372726
280 L>V No ClinGen
TOPMed
rs977245593
CA72543106
284 Q>R No ClinGen
Ensembl
CA2295043
rs751458590
285 R>K No ClinGen
ExAC
gnomAD
TCGA novel 286 Y>* Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1455448701
CA351817353
288 K>E No ClinGen
TOPMed
gnomAD
CA2295044
rs368706648
288 K>R No ClinGen
ESP
ExAC
gnomAD
CA351817379
rs1314522776
289 R>S No ClinGen
gnomAD
CA351817412
rs1227349406
292 I>V No ClinGen
gnomAD
CA351817552
rs1312281368
293 A>V No ClinGen
gnomAD
rs1283133155
CA351817564
295 S>N No ClinGen
gnomAD
rs767248740
CA2295062
296 T>A No ClinGen
ExAC
TOPMed
gnomAD
CA2295063
rs375479861
296 T>S No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA351817585
rs1252801725
RCV000731276
298 Y>C Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ClinVar
NCI-TCGA
dbSNP
gnomAD
rs911095503
CA72556441
299 I>T No ClinGen
TOPMed
gnomAD
CA351817597
rs1175408016
300 V>A No ClinGen
gnomAD
CA2295065
rs777753460
300 V>M No ClinGen
ExAC
gnomAD
CA72556461
rs768357801
302 L>F No ClinGen
Ensembl
CA2295066
rs753416887
303 I>M No ClinGen
ExAC
gnomAD
rs1375091494
CA351817636
306 M>I No ClinGen
TOPMed
CA351817632
rs1169058192
306 M>V No ClinGen
gnomAD
TCGA novel 307 Q>* Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA72556483
rs769653841
314 Q>H No ClinGen
TOPMed
gnomAD
rs138705864
CA2295068
316 I>V No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs775446748
CA72556485
323 A>S No ClinGen
Ensembl
TCGA novel 324 A>V Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
TCGA novel 326 G>= Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA351817788
rs1252026710
327 V>I No ClinGen
TOPMed
TCGA novel 333 A>T Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs753757676
CA2295085
335 A>S No ClinGen
ExAC
TOPMed
gnomAD
CA351817842
rs753757676
335 A>T No ClinGen
ExAC
TOPMed
gnomAD
rs1289417531
CA351817878
340 L>M No ClinGen
gnomAD
rs757140405
CA2295086
342 D>Y No ClinGen
ExAC
gnomAD
CA2295087
rs764761898
343 R>Q No ClinGen
ExAC
TOPMed
gnomAD
rs1268874500
CA351817912
345 T>I No ClinGen
TOPMed
rs749865173
CA2295088
346 K>E No ClinGen
ExAC
gnomAD
CA351817921
rs868830206
347 Q>E No ClinGen
gnomAD
rs1014856045
CA72558307
347 Q>H No ClinGen
TOPMed
CA72558301
rs868830206
347 Q>K No ClinGen
gnomAD
CA72558309
rs978927985
354 F>L Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
NCI-TCGA
TOPMed
gnomAD
TCGA novel 354 F>L Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
TCGA novel 355 L>W Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA351817982
rs1261801963
355 L>W No ClinGen
gnomAD
rs199702657
CA72558343
356 G>D No ClinGen
1000Genomes
rs757997959
CA2295089
356 G>R No ClinGen
ExAC
gnomAD
CA351817986
rs757997959
356 G>S No ClinGen
ExAC
gnomAD
rs779739661
CA2295090
357 V>I Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
TOPMed
gnomAD
CA2295091
rs149441473
358 S>L No ClinGen
ESP
ExAC
TOPMed
gnomAD
TCGA novel 358 S>P Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1319534710
CA351818006
360 A>S No ClinGen
gnomAD
TCGA novel 362 G>D Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs35863057
CA72558366
364 V>G No ClinGen
Ensembl
rs1347529045
CA351818048
367 S>G No ClinGen
gnomAD
CA351818050
rs1446279934
367 S>N No ClinGen
gnomAD
CA351818051
rs1446279934
367 S>T No ClinGen
gnomAD
CA351818055
rs1477841295
368 V>F No ClinGen
TOPMed
gnomAD
CA72558375
rs781596994
369 I>M No ClinGen
ExAC
TOPMed
gnomAD
rs759776467
CA2295094
370 Y>* No ClinGen
ExAC
rs1478247903
CA351818071
370 Y>C No ClinGen
TOPMed
CA2295095
rs748686430
371 L>F No ClinGen
ExAC
gnomAD
rs770359280
CA2295096
372 T>I No ClinGen
ExAC
TOPMed
gnomAD
rs770359280
CA72558402
372 T>S No ClinGen
ExAC
TOPMed
gnomAD
CA72558409
rs201657949
374 T>A No ClinGen
1000Genomes
TOPMed
rs1459883256
CA351818118
376 Y>H No ClinGen
TOPMed
CA2295125
rs773102441
384 F>C No ClinGen
ExAC
gnomAD
rs199778452
CA2295124
384 F>V No ClinGen
ExAC
TOPMed
gnomAD
rs74346226
CA2295126
385 Y>F No ClinGen
ExAC
gnomAD
CA2295128
rs765934760
386 S>L No ClinGen
ExAC
gnomAD
rs759242175
CA2295130
387 L>F No ClinGen
ExAC
gnomAD
CA2295131
rs767267914
389 D>G No ClinGen
ExAC
gnomAD
TCGA novel 391 G>= Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1371101429
CA351818223
391 G>E No ClinGen
TOPMed
rs1463182373
CA351818379
396 H>R No ClinGen
gnomAD
rs770240042
CA72560470
400 I>M No ClinGen
Ensembl
CA2295154
rs757800040
408 P>S No ClinGen
ExAC
rs1307726012
CA351818469
410 T>A No ClinGen
TOPMed
CA351818513
rs1195864010
416 F>V No ClinGen
gnomAD
CA351818557
rs1176884329
422 V>A No ClinGen
TOPMed
rs1379526780
CA351818553
422 V>I No ClinGen
TOPMed
rs935601300
CA72560488
423 C>Y No ClinGen
TOPMed
CA351818569
rs1165953656
424 T>N No ClinGen
gnomAD
CA2295159
rs747254166
426 P>S No ClinGen
ExAC
gnomAD
CA72560513
rs989482831
427 A>S No ClinGen
Ensembl
CA2295161
rs372395537
433 I>L No ClinGen
ESP
ExAC
gnomAD
rs749025136
CA2295162
435 N>I No ClinGen
ExAC
gnomAD
CA2295163
rs201775500
436 I>T No ClinGen
ExAC
TOPMed
gnomAD
CA2295164
rs774126425
437 N>S No ClinGen
ExAC
gnomAD
CA2295165
rs572795748
438 D>N No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
rs1559389195
CA351818672
439 E>G No ClinGen
Ensembl
CA351813499
rs1384624441
444 A>T No ClinGen
gnomAD
rs1044406953
CA72516784
447 A>T No ClinGen
TOPMed
rs896848010
CA72516786
450 A>T No ClinGen
TOPMed
TCGA novel 452 Y>C Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA351813566
rs1340516253
454 A>S No ClinGen
gnomAD
rs1252156465
CA351813601
459 R>Q No ClinGen
gnomAD
rs749665192
CA72516788
468 V>M Variant assessed as Somatic; impact. [NCI-TCGA] No ClinGen
Ensembl
NCI-TCGA
CA2295196
rs765539767
469 C>Y No ClinGen
ExAC
gnomAD
rs773524257
CA2295197
470 M>V Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
TOPMed
gnomAD
TCGA novel 471 L>M Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs766813650
CA2295199
474 I>V No ClinGen
ExAC
TOPMed
gnomAD
CA2295200
rs751705264
475 A>V No ClinGen
ExAC
gnomAD
rs1287197511
CA351813783
482 H>Q No ClinGen
gnomAD
CA351813793
rs1355979541
483 Y>C No ClinGen
gnomAD
CA351813821
rs1455933205
485 G>E Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
NCI-TCGA
gnomAD
CA2295203
rs752886119
486 D>N No ClinGen
ExAC
gnomAD
rs1490911382
CA351813842
487 D>N No ClinGen
TOPMed
CA2295205
rs369285498
495 V>M No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs750189081
CA2295206
499 S>G No ClinGen
ExAC
gnomAD
rs758472135
CA2295207
501 E>K No ClinGen
ExAC
gnomAD
CA351814038
rs1468989421
503 D>G No ClinGen
gnomAD
CA351814047
rs1354329053
504 K>R No ClinGen
TOPMed
TCGA novel 505 R>I Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1406624964
CA351814255
516 K>E No ClinGen
gnomAD
rs751562865
CA2295228
517 V>L No ClinGen
ExAC
gnomAD
rs751562865
COSM1485087
CA351814268
517 V>M Variant assessed as Somatic; impact. breast [NCI-TCGA, Cosmic] No ClinGen
cosmic curated
ExAC
NCI-TCGA
gnomAD
rs754901414
CA2295229
521 A>V No ClinGen
ExAC
gnomAD
TCGA novel 523 E>K Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1413376821
CA351814323
524 Q>K No ClinGen
gnomAD
CA351814363
rs1322260996
529 E>K No ClinGen
Ensembl
rs769389290
CA2295232
534 N>D No ClinGen
ExAC
gnomAD
rs771309912
CA2295235
535 I>M No ClinGen
ExAC
gnomAD
CA2295234
rs561872625
535 I>T No ClinGen
1000Genomes
ExAC
gnomAD
rs1033007030
CA72517318
536 K>R No ClinGen
TOPMed
CA72517325
rs1005310805
538 I>V No ClinGen
TOPMed
gnomAD
CA351814543
rs1437752985
546 L>V No ClinGen
gnomAD
CA351814585
rs1286132005
548 M>I No ClinGen
TOPMed
CA72517339
rs1018068238
548 M>V No ClinGen
TOPMed
rs1238760013
CA351814595
549 M>T No ClinGen
TOPMed
CA351814627
rs1486414201
551 A>S No ClinGen
TOPMed
gnomAD
rs772575777
CA2295238
555 T>I No ClinGen
ExAC
gnomAD
CA351814702
rs1341459156
556 W>L No ClinGen
TOPMed
rs373184320
CA2295243
572 Y>H No ClinGen
ESP
ExAC
gnomAD
CA2295245
rs751300317
573 N>S No ClinGen
ExAC
gnomAD
rs1559391072
CA351815022
576 G>S No ClinGen
Ensembl
rs1270680856
CA351815239
579 N>S No ClinGen
gnomAD
CA2295273
rs756006803
580 I>V No ClinGen
ExAC
TOPMed
gnomAD
TCGA novel 585 R>T Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
TCGA novel 586 E>G Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs34176522
CA2295276
588 Y>* No ClinGen
1000Genomes
ESP
ExAC
TOPMed
gnomAD
CA72517991
rs959547237
590 W>C No ClinGen
Ensembl
CA72517979
rs1033544431
590 W>L No ClinGen
Ensembl
rs200614759
CA72517995
592 R>S No ClinGen
Ensembl
CA2295277
rs778627115
595 T>R No ClinGen
ExAC
gnomAD
CA2295279
rs200387391
598 H>N No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
rs1475836521
CA351815502
598 H>R No ClinGen
gnomAD
rs200387391
CA2295280
598 H>Y No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
CA2295281
rs747579323
599 A>T No ClinGen
ExAC
TOPMed
gnomAD
rs769216142
CA2295282
599 A>V No ClinGen
ExAC
gnomAD
rs776862589
CA2295283
COSM1043571
600 R>Q Variant assessed as Somatic; 0.0 impact. endometrium [NCI-TCGA, Cosmic] No ClinGen
cosmic curated
ExAC
NCI-TCGA
TOPMed
gnomAD
CA351815527
rs1380466159
602 M>I No ClinGen
gnomAD
rs770207763
CA2295285
611 I>V No ClinGen
ExAC
gnomAD
rs1291106793
CA351815615
614 M>I No ClinGen
gnomAD
rs773452306
CA2295286
614 M>V No ClinGen
ExAC
gnomAD
rs1575447230
CA351815618
615 A>S No ClinGen
Ensembl
CA2295287
rs763036630
618 T>A No ClinGen
ExAC
gnomAD
rs1342556595
CA351815649
COSM185394
619 T>M large_intestine Variant assessed as Somatic; impact. [Cosmic, NCI-TCGA] No ClinGen
cosmic curated
NCI-TCGA
TOPMed
CA351815713
rs1447975360
628 N>T No ClinGen
gnomAD
CA2295293
rs761285199
633 L>R No ClinGen
ExAC
gnomAD
rs1575447670
CA351815772
635 G>E No ClinGen
Ensembl
CA351815790
rs1235407266
638 M>V No ClinGen
TOPMed
CA351815810
rs1292800840
641 N>D No ClinGen
TOPMed
rs368392285
CA351815832
644 A>P No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs368392285
CA2295321
644 A>S Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ESP
ExAC
NCI-TCGA
TOPMed
gnomAD
rs368392285
CA351815833
644 A>T No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA351815847
rs1318894845
646 Y>C No ClinGen
TOPMed
CA351815872
rs1347654338
649 M>I No ClinGen
TOPMed
gnomAD
rs755361919
CA2295322
650 R>G No ClinGen
ExAC
gnomAD
CA2295323
rs781776783
651 T>S No ClinGen
ExAC
gnomAD
TCGA novel 652 L>V Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
TCGA novel 657 V>F Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA2295326
rs371673458
657 V>L No ClinGen
ESP
ExAC
TOPMed
gnomAD
TCGA novel 660 I>N Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs78459547
CA72518571
669 G>C No ClinGen
Ensembl
rs1177774070
CA351816022
672 I>V No ClinGen
gnomAD
TCGA novel 680 R>S Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA2295330
rs201417158
681 I>V No ClinGen
1000Genomes
ExAC
gnomAD
TCGA novel 682 A>S Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1559392213
CA351816097
682 A>V No ClinGen
Ensembl
CA72518584
rs770988640
691 R>W No ClinGen
TOPMed
TCGA novel 694 D>H Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1352865205
CA351816201
695 Y>F No ClinGen
TOPMed
CA72520629
rs200616743
696 F>I No ClinGen
Ensembl
CA2295349
rs767464189
698 P>L No ClinGen
ExAC
CA2295351
rs139925773
701 E>G No ClinGen
ESP
ExAC
TOPMed
gnomAD
TCGA novel 702 F>V Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA2295352
rs747880110
703 R>C No ClinGen
ExAC
gnomAD
rs772991104
CA2295354
707 A>P No ClinGen
ExAC
TOPMed
gnomAD
CA351816284
rs1485446234
707 A>V No ClinGen
gnomAD
TCGA novel 708 G>E Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1474022009
CA351816307
711 T>S No ClinGen
gnomAD
TCGA novel 713 L>F Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs776066048
CA2295360
729 Q>R No ClinGen
ExAC
gnomAD
TCGA novel 735 P>L Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA351816498
rs1450370409
736 P>S No ClinGen
gnomAD
CA2295378
rs774981426
740 R>* No ClinGen
ExAC
gnomAD
rs1373898852
CA351816526
740 R>Q No ClinGen
TOPMed
rs201715710
CA72523351
746 I>T No ClinGen
Ensembl
TCGA novel 749 K>T Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs760322989
CA2295379
750 D>G No ClinGen
ExAC
gnomAD
CA2295380
rs768929346
751 I>V No ClinGen
ExAC
TOPMed
gnomAD
CA2295381
rs776991914
752 K>I No ClinGen
ExAC
TOPMed
gnomAD
CA351816684
rs776991914
752 K>T No ClinGen
ExAC
TOPMed
gnomAD
CA351816693
rs1345516378
753 F>V No ClinGen
gnomAD
CA351816786
rs1209676138
759 A>T No ClinGen
gnomAD
CA2295382
rs762244756
761 T>A No ClinGen
ExAC
gnomAD
CA2295385
rs762991862
767 V>F No ClinGen
ExAC
gnomAD
rs762991862
CA351816877
767 V>I No ClinGen
ExAC
gnomAD
rs751753111
CA2295387
768 R>K No ClinGen
ExAC
gnomAD
CA2295386
rs192589704
768 R>W No ClinGen
1000Genomes
ExAC
gnomAD
CA2295388
rs143283775
771 K>R No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA72523419
rs1048659729
774 A>T No ClinGen
TOPMed
gnomAD
rs1304535297
CA351816946
777 N>I No ClinGen
TOPMed
gnomAD
CA351816953
rs1403266371
778 R>T No ClinGen
gnomAD
rs1326876124
CA351816970
780 T>I No ClinGen
TOPMed
gnomAD
rs138530495
CA351816976
781 L>F No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA2295392
rs778960864
783 H>Q No ClinGen
ExAC
TOPMed
gnomAD
rs1447381628
CA351816990
783 H>R No ClinGen
gnomAD
rs771726674
CA2295394
785 P>R No ClinGen
ExAC
gnomAD
rs779573290
CA2295395
786 R>Q No ClinGen
ExAC
gnomAD
CA2295397
rs768301243
788 T>A No ClinGen
ExAC
gnomAD
CA2295398
rs372753354
788 T>S No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs773689570
CA2295401
790 I>V No ClinGen
ExAC
gnomAD
rs1467416140
CA351817059
794 Q>P No ClinGen
gnomAD
CA351817076
rs1198523742
796 Y>F No ClinGen
gnomAD
CA351817090
rs1294399605
798 S>* No ClinGen
TOPMed
CA2295424
rs770622300
801 T>S No ClinGen
ExAC
gnomAD
CA2295427
rs759628570
COSM1043574
806 R>C Variant assessed as Somatic; 0.0 impact. endometrium [NCI-TCGA, Cosmic] No ClinGen
cosmic curated
ExAC
NCI-TCGA
TOPMed
gnomAD
rs767679837
CA2295428
806 R>H No ClinGen
ExAC
TOPMed
gnomAD
rs1275045387
CA351817374
808 Y>C No ClinGen
TOPMed
TCGA novel 808 Y>H Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA351817392
rs1157247798
809 I>M No ClinGen
gnomAD
CA2295429
rs775875719
810 K>* No ClinGen
ExAC
gnomAD
rs1575452338
CA351817418
811 N>I No ClinGen
Ensembl
rs1358163514
CA351817438
812 K>N No ClinGen
gnomAD
CA351817447
TCGA novel
rs1575452345
814 V>F Variant assessed as Somatic; impact. [NCI-TCGA] No ClinGen
NCI-TCGA
Ensembl
CA351817470
rs1244668632
817 K>T No ClinGen
gnomAD
CA2295431
rs765124997
821 I>T No ClinGen
ExAC
gnomAD
COSM730335
rs868511799
CA72525779
822 S>F lung [Cosmic] No ClinGen
cosmic curated
Ensembl
TCGA novel 823 K>N Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs758472286
CA2295433
824 K>T No ClinGen
ExAC
gnomAD
TCGA novel 825 T>A Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1575452369
CA351817531
826 V>I No ClinGen
Ensembl

1 associated diseases with Q8TCJ2

[MIM: 615597]: Congenital disorder of glycosylation 1X (CDG1X)

A form of congenital disorder of glycosylation, a multisystem disorder caused by a defect in glycoprotein biosynthesis and characterized by under-glycosylated serum glycoproteins. Congenital disorders of glycosylation result in a wide variety of clinical features, such as defects in the nervous system development, psychomotor retardation, dysmorphic features, hypotonia, coagulation disorders, and immunodeficiency. The broad spectrum of features reflects the critical role of N-glycoproteins during embryonic development, differentiation, and maintenance of cell functions. {ECO:0000269|PubMed:23842455}. Note=The disease is caused by variants affecting the gene represented in this entry.

Without disease ID
  • A form of congenital disorder of glycosylation, a multisystem disorder caused by a defect in glycoprotein biosynthesis and characterized by under-glycosylated serum glycoproteins. Congenital disorders of glycosylation result in a wide variety of clinical features, such as defects in the nervous system development, psychomotor retardation, dysmorphic features, hypotonia, coagulation disorders, and immunodeficiency. The broad spectrum of features reflects the critical role of N-glycoproteins during embryonic development, differentiation, and maintenance of cell functions. {ECO:0000269|PubMed:23842455}. Note=The disease is caused by variants affecting the gene represented in this entry.

No regional properties for Q8TCJ2

Type Name Position InterPro Accession
No domain, repeats, and functional sites for Q8TCJ2

Functions

Description
EC Number 2.4.99.18 Transferring other glycosyl groups
Subcellular Localization
  • Endoplasmic reticulum
  • Endoplasmic reticulum membrane; Multi-pass membrane protein
PANTHER Family
PANTHER Subfamily
PANTHER Protein Class
PANTHER Pathway Category No pathway information available

7 GO annotations of cellular component

Name Definition
endoplasmic reticulum The irregular network of unit membranes, visible only by electron microscopy, that occurs in the cytoplasm of many eukaryotic cells. The membranes form a complex meshwork of tubular channels, which are often expanded into slitlike cavities called cisternae. The ER takes two forms, rough (or granular), with ribosomes adhering to the outer surface, and smooth (with no ribosomes attached).
endoplasmic reticulum membrane The lipid bilayer surrounding the endoplasmic reticulum.
integral component of membrane The component of a membrane consisting of the gene products and protein complexes having at least some part of their peptide sequence embedded in the hydrophobic region of the membrane.
membrane A lipid bilayer along with all the proteins and protein complexes embedded in it an attached to it.
oligosaccharyltransferase complex A protein complex that is found in the endoplasmic reticulum membrane of eukaryotes and transfers lipid-linked oligosaccharide precursor to asparagine residues on nascent proteins. In yeast, the complex includes at least nine different subunits, whereas in mammalian cells at least three different forms of the complex have been detected.
oligosaccharyltransferase I complex An oligosaccharyltransferase (OST) complex that contains at least seven polypeptides and is the major OST complex in mammalian cells. Of the three forms of mammalian OST complex identified, the OSTI complex has the weakest affinity for ribosomes.
protein-containing complex A stable assembly of two or more macromolecules, i.e. proteins, nucleic acids, carbohydrates or lipids, in which at least one component is a protein and the constituent parts function together.

2 GO annotations of molecular function

Name Definition
dolichyl-diphosphooligosaccharide-protein glycotransferase activity Catalysis of the reaction: dolichyl diphosphooligosaccharide + protein L-asparagine = dolichyl diphosphate + a glycoprotein with the oligosaccharide chain attached by glycosylamine linkage to protein L-asparagine.
metal ion binding Binding to a metal ion.

7 GO annotations of biological process

Name Definition
co-translational protein modification The process of covalently altering one or more amino acids in a protein after translation has begun but before the protein has been released from the ribosome.
glycoprotein catabolic process The chemical reactions and pathways resulting in the breakdown of a glycoprotein, a protein that contains covalently bound glycose (i.e. monosaccharide) residues; the glycose occurs most commonly as oligosaccharide or fairly small polysaccharide but occasionally as monosaccharide.
post-translational protein modification The process of covalently altering one or more amino acids in a protein after the protein has been completely translated and released from the ribosome.
protein N-linked glycosylation A protein glycosylation process in which a carbohydrate or carbohydrate derivative unit is added to a protein via the N4 atom of peptidyl-asparagine, the omega-N of arginine, or the N1' atom peptidyl-tryptophan.
protein N-linked glycosylation via asparagine The glycosylation of protein via the N4 atom of peptidyl-asparagine forming N4-glycosyl-L-asparagine; the most common form is N-acetylglucosaminyl asparagine; N-acetylgalactosaminyl asparagine and N4 glucosyl asparagine also occur. This modification typically occurs in extracellular peptides with an N-X-(ST) motif. Partial modification has been observed to occur with cysteine, rather than serine or threonine, in the third position; secondary structure features are important, and proline in the second or fourth positions inhibits modification.
response to unfolded protein Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an unfolded protein stimulus.
ubiquitin-dependent ERAD pathway The series of steps necessary to target endoplasmic reticulum (ER)-resident proteins for degradation by the cytoplasmic proteasome. Begins with recognition of the ER-resident protein, includes retrotranslocation (dislocation) of the protein from the ER to the cytosol, protein ubiquitination necessary for correct substrate transfer, transport of the protein to the proteasome, and ends with degradation of the protein by the cytoplasmic proteasome.

9 homologous proteins in AiPD

UniProt AC Gene Name Protein Name Species Evidence Code
P39007 STT3 Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit STT3 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) (Baker's yeast) PR
Q2KJI2 STT3A Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit STT3A Bos taurus (Bovine) PR
P46977 STT3A Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit STT3A Homo sapiens (Human) PR
P46978 Stt3a Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit STT3A Mus musculus (Mouse) PR
Q3TDQ1 Stt3b Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit STT3B Mus musculus (Mouse) PR
Q7XQ88 STT3B Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit STT3B Oryza sativa subsp japonica (Rice) PR
P46975 stt-3 Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit stt-3 Caenorhabditis elegans PR
Q93ZY3 STT3A Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit STT3A Arabidopsis thaliana (Mouse-ear cress) PR
Q9FX21 STT3B Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit STT3B Arabidopsis thaliana (Mouse-ear cress) PR
10 20 30 40 50 60
MAEPSAPESK HKSSLNSSPW SGLMALGNSR HGHHGPGAQC AHKAAGGAAP PKPAPAGLSG
70 80 90 100 110 120
GLSQPAGWQS LLSFTILFLA WLAGFSSRLF AVIRFESIIH EFDPWFNYRS THHLASHGFY
130 140 150 160 170 180
EFLNWFDERA WYPLGRIVGG TVYPGLMITA GLIHWILNTL NITVHIRDVC VFLAPTFSGL
190 200 210 220 230 240
TSISTFLLTR ELWNQGAGLL AACFIAIVPG YISRSVAGSF DNEGIAIFAL QFTYYLWVKS
250 260 270 280 290 300
VKTGSVFWTM CCCLSYFYMV SAWGGYVFII NLIPLHVFVL LLMQRYSKRV YIAYSTFYIV
310 320 330 340 350 360
GLILSMQIPF VGFQPIRTSE HMAAAGVFAL LQAYAFLQYL RDRLTKQEFQ TLFFLGVSLA
370 380 390 400 410 420
AGAVFLSVIY LTYTGYIAPW SGRFYSLWDT GYAKIHIPII ASVSEHQPTT WVSFFFDLHI
430 440 450 460 470 480
LVCTFPAGLW FCIKNINDER VFVALYAISA VYFAGVMVRL MLTLTPVVCM LSAIAFSNVF
490 500 510 520 530 540
EHYLGDDMKR ENPPVEDSSD EDDKRNQGNL YDKAGKVRKH ATEQEKTEEG LGPNIKSIVT
550 560 570 580 590 600
MLMLMLLMMF AVHCTWVTSN AYSSPSVVLA SYNHDGTRNI LDDFREAYFW LRQNTDEHAR
610 620 630 640 650 660
VMSWWDYGYQ IAGMANRTTL VDNNTWNNSH IALVGKAMSS NETAAYKIMR TLDVDYVLVI
670 680 690 700 710 720
FGGVIGYSGD DINKFLWMVR IAEGEHPKDI RESDYFTPQG EFRVDKAGSP TLLNCLMYKM
730 740 750 760 770 780
SYYRFGEMQL DFRTPPGFDR TRNAEIGNKD IKFKHLEEAF TSEHWLVRIY KVKAPDNRET
790 800 810 820
LDHKPRVTNI FPKQKYLSKK TTKRKRGYIK NKLVFKKGKK ISKKTV